The rationale for integration of lymphatic mapping and sentinel node biopsy in the management of breast cancer after neoadjuvant chemotherapy

Seminars in Breast Disease

Volumn 5, Issue 2, 2002, Pages 80-87

  Kuerer, Henry M ^a   Hunt, Kelly K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN;

AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CONFERENCE PAPER; FEMALE; HUMAN; INOPERABLE CANCER; LYMPH NODE METASTASIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SAFETY; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

EID: 0036302652     PISSN: 10924450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer
2. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
3. Multimodal treatment of locoregionally advanced breast cancer
4. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
5. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
6. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
7. Carcinoma of the breast. II. Criteria of operability
8. Locally advanced noninflammatory breast cancer
9. Breast cancer: Relationship between the size of the primary tumour and the probability of metastatic dissemination
10. Primary chemotherapy in surgically resectable breast cancer
11. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer
12. Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute
13. Neoadjuvant chemotherapy in women with invasive breast carcinoma: Conceptual basis and fundamental surgical issues
14. The effect on primary rumor response of adding seqential taxotere to adriamycin and cyclophosphamide: Preliminary results from NSABP protocol B-27
15. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy
16. Pathologic rumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status
17. New approaches to surgery for breast cancer
18. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials
19. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer
20. Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes
21. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation
22. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors
23. Role for sentinel lymph node dissection in the management of large (≥5 cm) invasive breast cancer
24. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer
25. Lymphatic mapping and sentinel node biopsy is accurate following preoperative chemotherapy for breast cancer
26. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy
27. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma
28. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme
29. Sentinel node biopsy following neoadjuvant chemotherapy in breast cancer: Results from NSABP B-27
30. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma?
31. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer
32. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer
33. Prospective evaluation of accuracy of lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for locally advanced breast cancer
34. Sentinel lymph node accuracy following neoadjuvant chemotherapy in breast cancer